Adverum Biotechnologies Inc (ADVM)
5.80
+0.05
(+0.87%)
USD |
NASDAQ |
Nov 22, 10:27
Adverum Biotechnologies Profit Margin (Quarterly): -2.71K% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -2.71K% |
| June 30, 2024 | |
| March 31, 2024 | |
| December 31, 2023 | |
| September 30, 2023 | |
| June 30, 2023 | |
| March 31, 2023 | -807.1% |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | -379.1% |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | |
| September 30, 2019 | -6.45K% |
| June 30, 2019 |
| Date | Value |
|---|---|
| March 31, 2019 | |
| December 31, 2018 | -22.37K% |
| September 30, 2018 | -2.52K% |
| June 30, 2018 | -3.82K% |
| March 31, 2018 | -7.96K% |
| December 31, 2017 | -3.21K% |
| September 30, 2017 | -2.99K% |
| June 30, 2017 | -2.47K% |
| March 31, 2017 | -3.48K% |
| December 31, 2016 | -4.59K% |
| September 30, 2016 | -3.62K% |
| June 30, 2016 | -20.08K% |
| March 31, 2016 | -5.81K% |
| December 31, 2015 | -1.47K% |
| September 30, 2015 | -1.48K% |
| June 30, 2015 | -4.81K% |
| March 31, 2015 | -4.68K% |
| December 31, 2014 | -5.12K% |
| September 30, 2014 | -4.05K% |
| June 30, 2014 | -3.77K% |
| March 31, 2014 | -5.54K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-2.71K%
Minimum
Sep 2024
-379.1%
Maximum
Mar 2021
-1.30K%
Average
-807.1%
Median
Mar 2023
Profit Margin (Quarterly) Benchmarks
| EyePoint Pharmaceuticals Inc | -279.0% |
| Cassava Sciences Inc | -- |
| Regenxbio Inc | -246.3% |
| Editas Medicine Inc | -101.9K% |
| Apellis Pharmaceuticals Inc | -29.19% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -69.14% |
| Return on Assets | -41.80% |
| Return on Invested Capital | -69.14% |
| Operating Margin (Quarterly) | -2.92K% |
| Return on Net Operating Assets | -143.5% |